Speeches by FDA Officials
Speeches by the Commissioner of Food and Drugs
October 2016
- October 17, 2016 - Critical Lessons About Rare Disease Drug Development
Speech by Robert M. Califf, Washington D.C.
July 2016
- July 06, 2016 - Incorporating the Public Health Impact Into the Risk-Benefit Assessment for Opioids
Dr. Robert M. Califf’s charge to the National Academy of Science, Engineering and Medicine’s Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse, Keck Center, Washington, DC
May 2016
- May 05, 2016 - Speech by Commissioner Robert M. Califf to the 2016 FDLI Annual Meeting
Washington, D.C. - May 05, 2016 - Remarks by Robert Califf to the Medical Device Manufacturers Association
FDA's Broader Vision Remarks by Dr. Robert Califf to the MMDA Washington, DC
March 2016
- March 29, 2016 - Speech by FDA Commissioner Robert M. Califf to the 2016 Rx Opioid and Drug Abuse Summit
Atlanta, Georgia
October 2015
- October 27, 2015 - "Responding to Changing Regulatory Needs with Care and Due Diligence" -- Remarks to the Regulatory Affairs Professional Society
Baltimore, Maryland - October 23, 2015 - Disability Employment Awareness
White Oak, Maryland - October 22, 2015 - " The Central Role of Patients in Developing Products for Rare Diseases" -- Remarks by Stephen M. Ostroff, M.D.
Alexandria, Virginia - October 01, 2015 - Speech by Dr. Stephen M. Ostroff to the Missouri Biotechnology Association
Life Sciences Dinner, St. Louis, Missouri
September 2015
- September 25, 2015 - Priming the Innovation Pump -- FDA's Role in Advancing and Using Next Generation Sequencing
American Society of Microbiology Washington, D.C.
June 2015
- June 03, 2015 - Remarks to the Alliance for a Stronger FDA
Washington, DC
May 2015
- May 08, 2015 - Recent Developments in Combating Antibiotic Resistance: FDA's Role
Washington, D.C.
April 2015
- April 20, 2015 - Remarks at the 2015 Annual Conference of the Food and Drug Law Institute, Washington, D.C.
Stephen Ostroff, M.D., Acting Commissioner of Food and Drugs - April 07, 2015 - National Prescription Drug Abuse Summit
Remarks by Acting Commissioner Stephen Ostroff, M.D., Atlanta, Georgia
March 2015
- March 27, 2015 - Lessons Learned: How the FDA Matters
Remarks by Margaret A. Hamburg, M.D., National Press Club, Washington, DC - March 18, 2015 - European Medicines Agency 20th Anniversary Meeting
Remarks by Margaret A. Hamburg, M.D., London, England
February 2015
- February 20, 2015 - Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests
Remarks by Margaret A. Hamburg, M.D., National Institutes of Health
January 2015
- January 27, 2015 - Stand Up to Cancer Summit
Santa Monica, California
December 2014
- December 18, 2014 - FDA Strategies for Combatting Antimicrobial Resistance
Remarks by Margaret A. Hamburg, M.D., A One Health Colloquium, London, England - December 12, 2014 - Introductory Remarks, Workshop on Immunology of Protection from Ebola Virus Infection
Remarks by Margaret A. Hamburg, M.D., NIAID Fishers Lane Conference Center, Rockville, Maryland - December 02, 2014 - FDA and Women’s Health: Good Science Means Better Care
Remarks by Margaret A. Hamburg, M.D., George Washington University, Washington, DC
November 2014
- November 17, 2014 - Meeting the Challenges of Globalization and Strengthening International Collaboration for Improved Health and Safety
Peking University, Beijing, People's Republic of China - November 12, 2014 - The FDA and Personalized Medicine – Forging a New Era of Progress
Personalized Medicine Conference, Boston, Massachusetts
October 2014
- October 24, 2014 - Keynote Address, Second Annual Pediatric Surgical Innovation Symposium, Lessons from Drugs to Devices: A Pediatric Perspective
Washington, D.C. - October 22, 2014 - A Pivotal Moment for the Treatment of Rare Diseases -- Address by Dr. Margaret A. Hamburg to the NORD Rare Diseases and Orphan Products Breakthrough Summit
Alexandria, Virginia
September 2014
- September 26, 2014 - Remarks by Commissioner Margaret A. Hamburg on the dedication of the Biodefense Laboratory Complex at the White Oak Campus
Washington, DC - September 10, 2014 - Speech by Dr. Margaret Hamburg to the Colorado BioScience Association
April 2014
- April 23, 2014 - Speech by Dr. Hamburg to the Food and Drug Law Institute (FDLI) 2014 Annual Conference
Washington, D.C. - April 22, 2014 - Regulating in an Era of Increasingly Sophisticated Medicines – Striking the Balance Between Patient Benefits and Risks -- An Address by Dr. Margaret Hamburg to the National Rx Drug Abuse Summit
Atlanta, Georgia - April 03, 2014 - Prescription Opioid Abuse and Misuse Issues: FDA Briefing for Stakeholders
Washington, DC - April 01, 2014 - Part 15 Public Hearing on Section 907 of FDASIA
The Great Room, White Oak Bldg. 31 Silver Spring, MD
March 2014
- March 06, 2014 - "New Realities of Globalization -- Implications for Health, Medicine and the Role of the Regulator"
Medicines and Healthcare Products Regulatory Agency (MHRA) Annual Lecture 2014, London, England
February 2014
- February 27, 2014 - Remarks on the Proposed Updates to the Nutrition Facts Label
Let's Move announcement, Washington, D.C. - February 26, 2014 - Science, Collaboration and Smart Regulation: Catalyst for Medical Opportunity
CED Life Science Conference, Raleigh, North Carolina - February 17, 2014 - Global Reach, Global Safety -- Recipes to Ensure the Quality of Spices
Remarks by Margaret A. Hamburg, M.D.,World Spice Congress, Cochin, India - February 04, 2014 - Remarks on the Launch of The Real Cost Campaign
National Press Club, Washington, DC
January 2014
- January 28, 2014 - Stand Up to Cancer Scientific Summit 2014
Remarks by Margaret A. Hamburg, M.D., Pasadena, CA
- Previous
- 1